FDA Investigator George Ivan Wey
George Ivan Wey has conducted inspections on 15 sites in 1 countries as of 30 Apr 2002. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
30 Apr 2002
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with George Ivan Wey:
Brian R Cronenwett,
Carl J Montgomery,
Carmen Y Fisher,
Catherine Whiteside, PhD,
Chris A Sack,
Cynthia L Evitt,
Diana M Guidry,
Dr. Abhijit Raha, PhD,
Eric C Nielsen,
Eric M Mueller, PharmD,
Jane E Nelson,
Jeffery A Hangartner,
Jessica E Hensley,
Jessica L Peterson,
Jin Young Park, PhD,
John A Iwen,
John J Welsh, PhD,
Jonathan R Campos,
Joseph R Lambert,
Jyoti B Patel, PhD,
Kara L Roden,
Karen M Montgomery (KMM),
Kevin A Beavers,
Kristi M Hampton Thurston,
Latonya M Mitchell,
LCDR Audra J Lenhart,
LCDR Ismael Olvera, IV,
Linda R Kuchenthal,
Lori A Gioia,
Michael F Skelly, PhD,
Mohsen Rajabi Abhari, FDA,
Nilufer M Tampal, PhD,
Pamela L Velez Vega,
Patrick L Wisor,
Rodney D Combs,
Shirley J Berryman,
Susanna E Ford,
Ted L Anderson,
Vickie J Kanion,
William F Lagud, Jr,
Xikui Chen (nmi), PhD,
Yiyue Zhang (nmi), PhD
George Ivan Wey's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2000 | EIR | Lem, Dr Vincent - EIR, 2000-07-14 |
July, 2000 | FDA 483 | Multiple Physician Clinical Research - Form 483, 2000-07-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more